Back
Thungela Resources Vs. Aligos Therapeutics Industry Stock Comparison
Buy
52
TNGRF
Thungela Resources
Last Price:
7.05
Seasonality Move:
34.04%
Buy
72
ALGS
Aligos Therapeutics
Last Price:
33.28
Seasonality Move:
10.65%
Buy
52
Thungela Resources (TNGRF)
is a Buy
Is Thungela Resources a Buy, Sell or Hold?
- The current Thungela Resources [TNGRF] share price is $7.05. The Score for TNGRF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- TNGRF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $33.11. The Score for ALGS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TNGRF Stock Price Chart
What is Thungela Resources's stock price today?
-
The Thungela Resources share price today is $7.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNGRF is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $33.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
TNGRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 49.99 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.85 | Buy |
| Relative Strength Index (14 RSI): | 78.88 | Buy |
| Chaikin Money Flow: | -127407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.12 - 28.52) | Buy |
| Bollinger Bands (100): | (7.57 - 20.11) | Buy |
TNGRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.87 | Buy |
| 20-day SMA: | 7.14 | Sell |
| 50-day SMA: | 7.1 | Sell |
| 200-day SMA: | 6.74 | Buy |
| 8-day EMA: | 6.94 | Buy |
| 20-day EMA: | 7.03 | Buy |
| 50-day EMA: | 7 | Buy |
| 200-day EMA: | 7.02 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.4 | Buy |
| 20-day SMA: | 24.33 | Buy |
| 50-day SMA: | 15.25 | Buy |
| 200-day SMA: | 15.91 | Buy |
| 8-day EMA: | 29.74 | Buy |
| 20-day EMA: | 24.86 | Buy |
| 50-day EMA: | 18.75 | Buy |
| 200-day EMA: | 16.3 | Buy |
Thungela Resources Earnings Growth & TNGRF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Thungela Resources Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||